NCT01658696View on ClinicalTrials.gov

Efficacy of Candidate Malaria Vaccines in Senegalese Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Malaria
Interventions
BIOLOGICAL

ChAd63 ME-TRAP and MVA ME-TRAP

ChAd63 ME-TRAP: 5 x 10\^10vp MVA ME-TRAP: 2 x 10\^8 pfu heterologous prime-boost immunisation

BIOLOGICAL

Rabies vaccine

2 x 2.5IU Verorab

Trial Locations (1)

BP 5005

University Cheikh Anta Diop (UCAD), Dakar

All Listed Sponsors
collaborator

European and Developing Countries Clinical Trials Partnership (EDCTP)

OTHER_GOV

lead

University of Oxford

OTHER

NCT01658696 - Efficacy of Candidate Malaria Vaccines in Senegalese Adults | Biotech Hunter | Biotech Hunter